Topical morphine gel can help to ease pain related to wounds in people with epidermolysis bullosa (EB), a new…
Articles by Marisa Wexler, MS
Blocking the activity of an immune cell receptor protein called FcyRIV prevented the development of epidermolysis bullosa acquisita in…
The effect of epidermolysis bullosa (EB) on oral health significantly affects the quality of life of children living with…
Filsuvez (Oleogel-S10) has been approved in Great Britain — England, Scotland and Wales — for treating wounds associated with…
People with dystrophic epidermolysis bullosa (DEB) saw the total surface of their wounds significantly reduced after being treated with…
Skin tumors called cutaneous squamous cell carcinomas (cSCCs) are common in people with certain types of epidermolysis bullosa…
Treatment with the experimental protein replacement therapy PTR-01 promoted wound healing and decreased pain in people with recessive dystrophic epidermolysis…
The European Commission is expected to propose a new governing framework for health data next month, called the European Health…
The antibiotic gentamicin, given via an infusion into the bloodstream, promoted wound closure and increased the production of laminin 332…
Treatment with ointment containing a low dose of calcipotriol — an analog (similar compound) of vitamin D3 — helped to…
Treatment with Abeona Therapeutics‘ investigational cell therapy EB-101 led to successful wound healing and eased pain in seven…
Eurordis opened a campaign, called Rare 2030 Action, that is seeking to establish a European action plan for…